LPTX   $0.39  3.13% Market Closed

Leap Therapeutics Inc
Total Cash 78.48M
totalCashPerShare 2.051
EBITDA -64.69M
Total Debt 482.00K
quickRatio 5.079
currentRatio 5.102
Total Revenue
debtToEquity 0.733
Revenue/Share
ROA -0.45619
ROE -0.80541
grossProfits
freeCashflow -30.07M
operatingCashflow -50.05M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 9.63M
forwardPE -1.9120001
floatShares 26.57M
sharesOutstanding 38.26M
sharesShort 899.10K
sharesShortPriorMonth 1.04M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.14%
heldPercentInstitutions 0.40%
Short Ratio help_outline 6.71%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 1.719
Price To Book help_outline 1.39
earningsQuarterlyGrowth
netIncomeToCommon -60.34M
trailingEps -0.98%
forwardEps -1.25%
enterpriseToEbitda -0.15
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.48 3Q 2024
institutionsCount 54
lastUpdated Oct. 16, 2024, 6:53 p.m.